Literature DB >> 30788351

Who will benefit from thymectomy for myasthenia gravis? Is there any role for this procedure in elderly patients?

Ryo Otsuka1, Kazuhiro Ueda1, Toshiki Tanaka1, Junichi Murakami1, Masataro Hayashi1, Kimikazu Hamano1.   

Abstract

BACKGROUND: The proportion of elderly patients with myasthenia gravis (MG) is increasing over time. Thoracoscopic extended thymectomy has been shown to achieve a superior short-term outcome to transsternal procedures. Therefore, the long-term clinical outcome should be re-examined, particularly in elderly patients.
METHODS: We evaluated the long-term clinical outcomes after extended thymectomy in 30 MG patients with or without thymoma. Twenty-one (70%) patients underwent surgery by 65 years of age, and the remaining 9 (30%) underwent surgery after 65 years of age. Univariate and multivariate logistic regression analyses were used to determine the influence of various factors on the improvement in MG symptoms.
RESULTS: The characteristics in the elderly patients were comparable to those in the younger patients, except for the age at surgery. Symptoms of MG improved in 4 of the 9 (44%) elderly patients and in 18 of the 21 (86%) younger patients (P=0.0192). One elderly patient who underwent transsternal thymectomy died suddenly on postoperative day 3, probably due to a MG crisis: no pathological abnormalities were detected by an autopsy. A multivariate analysis identified an age at thymectomy of <65 years (P=0.0237) and a duration from the onset to thymectomy of <1 year (P=0.0405) as independent factors associated with the improvement of MG symptoms. Indeed, 4 of the 5 (80%) elderly patients who underwent thymectomy within 1 year after the onset had a favorable long-term outcome.
CONCLUSIONS: Thymectomy can be an option even in elderly patients, provided the operation is performed early after the onset.

Entities:  

Keywords:  Myasthenia gravis (MG); elderly patients; thoracoscopy; thymectomy; thymoma

Year:  2019        PMID: 30788351      PMCID: PMC6351377          DOI: 10.21037/atm.2018.11.66

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  16 in total

1.  Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  G S Gronseth; R J Barohn
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

2.  Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.

Authors:  Finn E Somnier
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients.

Authors:  E Beghi; C Antozzi; A P Batocchi; F Cornelio; V Cosi; A Evoli; M Lombardi; R Mantegazza; M L Monticelli; G Piccolo
Journal:  J Neurol Sci       Date:  1991-12       Impact factor: 3.181

4.  MYASTHENIA GRAVIS AND TUMORS OF THE THYMIC REGION: REPORT OF A CASE IN WHICH THE TUMOR WAS REMOVED.

Authors:  A Blalock; M F Mason; H J Morgan; S S Riven
Journal:  Ann Surg       Date:  1939-10       Impact factor: 12.969

5.  Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis.

Authors:  M Tsuchida; Y Yamato; T Souma; K Yoshiya; T Watanabe; T Aoki; J Hayashi
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

6.  Analysis of thymectomy for myasthenia gravis in older patients: a 20-year single institution experience.

Authors:  P L Abt; H J Patel; A Marsh; S I Schwartz
Journal:  J Am Coll Surg       Date:  2001-04       Impact factor: 6.113

7.  Long-term follow up of thymus in patients with myasthenia gravis.

Authors:  Masashiro Sugawara; Chizu Wada; Satoshi Okawa; Michio Kobayashi; Erika Abe; Koji Obara; Sachiko Kamada; Hirohide Ohnishi; Itaru Toyoshima
Journal:  J Neuroimmunol       Date:  2010-01-27       Impact factor: 3.478

Review 8.  Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

Authors:  A Jaretzki; R J Barohn; R M Ernstoff; H J Kaminski; J C Keesey; A S Penn; D B Sanders
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

9.  Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan.

Authors:  Masayuki Matsuda; Naoko Dohi-Iijima; Akinori Nakamura; Yoshiki Sekijima; Hiroshi Morita; Shigeyuki Matsuzawa; Shun-Ichi Sato; Hiroyuki Yahikozawa; Ken-Ichi Tabata; Sohei Yanagawa; Shu-Ichi Ikeda
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

Review 10.  Video-assisted thoracoscopic surgery or transsternal thymectomy in the treatment of myasthenia gravis?

Authors:  Imran Zahid; Sumera Sharif; Tom Routledge; Marco Scarci
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-10-13
View more
  2 in total

1.  Thymectomy in Non-Thymomatous Myasthenia Gravis: Does An RCT Solve The 75-Year-Old Controversy?

Authors:  Nishita Singh; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2019-12-18       Impact factor: 1.383

2.  Perioperative outcomes and mid-term effects in performing video-assisted thoracoscopic extended thymectomy for myasthenia gravis: subxiphoid versus right thoracic approaches.

Authors:  Zhihong Qiu; Liru Chen; Qin Lin; Hao Wu; Huangtao Sun; Xin Zhou; Yeji Hu; Lei Peng; Yangchun Liu; Quan Xu
Journal:  J Thorac Dis       Date:  2020-04       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.